230 related articles for article (PubMed ID: 29444989)
1. Introducing the new BTS guideline: the investigation and management of pleural malignant mesothelioma.
Woolhouse I; Maskell NA
Thorax; 2018 Mar; 73(3):210-212. PubMed ID: 29444989
[No Abstract] [Full Text] [Related]
2. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline Summary.
Kindler HL; Ismaila N; Hassan R
J Oncol Pract; 2018 Apr; 14(4):256-264. PubMed ID: 29517955
[No Abstract] [Full Text] [Related]
3. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
[TBL] [Abstract][Full Text] [Related]
4. [Clinical Pathological Diagnosis, and Treatment for Pleural Mesothelioma].
Kishimoto T; Fujimoto N; Nishi H
Gan To Kagaku Ryoho; 2016 May; 43(5):513-7. PubMed ID: 27210080
[TBL] [Abstract][Full Text] [Related]
5. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Popat S; Baas P; Faivre-Finn C; Girard N; Nicholson AG; Nowak AK; Opitz I; Scherpereel A; Reck M;
Ann Oncol; 2022 Feb; 33(2):129-142. PubMed ID: 34861373
[No Abstract] [Full Text] [Related]
6. The role of microRNAs in the diagnosis and treatment of malignant pleural mesothelioma--a short review.
Sheff KW; Hoda MA; Dome B; Hegedus B; Klepetko W; Weiss GJ
Microrna; 2012; 1(1):40-8. PubMed ID: 25048089
[TBL] [Abstract][Full Text] [Related]
7. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Baas P; Fennell D; Kerr KM; Van Schil PE; Haas RL; Peters S;
Ann Oncol; 2015 Sep; 26 Suppl 5():v31-9. PubMed ID: 26223247
[No Abstract] [Full Text] [Related]
8. Malignant Pleural Mesothelioma: The Last 8 Years of Experience in Our Area.
Benítez JC; Campayo M; Call S; Bastús R
Arch Bronconeumol (Engl Ed); 2018 Dec; 54(12):637-638. PubMed ID: 29804950
[No Abstract] [Full Text] [Related]
9. [Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition)].
Multidisciplinary Committee of Oncology, Chinese Physicians Association
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):383-394. PubMed ID: 33902201
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Kindler HL; Ismaila N; Armato SG; Bueno R; Hesdorffer M; Jahan T; Jones CM; Miettinen M; Pass H; Rimner A; Rusch V; Sterman D; Thomas A; Hassan R
J Clin Oncol; 2018 May; 36(13):1343-1373. PubMed ID: 29346042
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F
Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Zentralbl Chir; 2018 Feb; 143(1):14. PubMed ID: 29482232
[No Abstract] [Full Text] [Related]
13. Malignant Pleural Mesothelioma: Diagnosis, Staging, Pitfalls and Follow-up.
Odisio EG; Marom EM; Shroff GS; Wu CC; Benveniste APA; Truong MT; Benveniste MF
Semin Ultrasound CT MR; 2017 Dec; 38(6):559-570. PubMed ID: 29179896
[TBL] [Abstract][Full Text] [Related]
14. [Malignant pleural mesothelioma].
Sritharan SS; Frandsen JL; Omland Ø; Bruun JM
Ugeskr Laeger; 2018 Apr; 180(15):. PubMed ID: 29690982
[TBL] [Abstract][Full Text] [Related]
15. A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial.
Gunatilake S; Brims FJ; Fogg C; Lawrie I; Maskell N; Forbes K; Rahman N; Morris S; Ogollah R; Gerry S; Peake M; Darlison L; Chauhan AJ
Trials; 2014 Sep; 15():367. PubMed ID: 25238873
[TBL] [Abstract][Full Text] [Related]
16. A Narrative Review-Management of Malignant Pleural Effusion Related to Malignant Pleural Mesothelioma.
Qureshi M; Thapa B; Muruganandan S
Heart Lung Circ; 2023 May; 32(5):587-595. PubMed ID: 36925448
[TBL] [Abstract][Full Text] [Related]
17. Advances in treatment of mesothelioma.
Maggioni C; Barletta G; Rijavec E; Biello F; Gualco E; Grossi F
Expert Opin Pharmacother; 2016 Jun; 17(9):1197-205. PubMed ID: 27055148
[TBL] [Abstract][Full Text] [Related]
18. The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
Novello S; Pinto C; Torri V; Porcu L; Di Maio M; Tiseo M; Ceresoli G; Magnani C; Silvestri S; Veltri A; Papotti M; Rossi G; Ricardi U; Trodella L; Rea F; Facciolo F; Granieri A; Zagonel V; Scagliotti G
Crit Rev Oncol Hematol; 2016 Aug; 104():9-20. PubMed ID: 27286698
[TBL] [Abstract][Full Text] [Related]
19. Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours.
Dumoulin DW; Bironzo P; Passiglia F; Scagliotti GV; Aerts JGJV;
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36754434
[TBL] [Abstract][Full Text] [Related]
20. Is There Room for Second-Line Treatment of Pleural Malignant Mesothelioma?
Addeo A; Buffoni L; Di Maio M
JAMA Oncol; 2017 Sep; 3(9):1170-1171. PubMed ID: 28114625
[No Abstract] [Full Text] [Related]
[Next] [New Search]
